Eli Lilly to buy bowel disease drug developer Morphic for $3.2bn
Eli Lilly to acquire Morphic Holding companies said Monday that for $3.2 billion in cash, they will give the U.S. drugmaker access to an experimental drug to treat various inflammatory bowel diseases.
BELIEBTE BEITRÄGE
Colombia was the deadliest country for environmentalists in 2023
September 11, 2024
Floods inundate northern Vietnam, Typhoon Yagi death toll rises
September 11, 2024
Destin Daniel Cretton in talks to direct ‘Spider-Man 4’
September 11, 2024
LIVEÜBERTRAGUNG